Umamaheswar Duvvuri, MD, PhD, assistant professor of Otolaryngology (ENT) at the University of Pittsburgh Medical Center, talks about potential genetic signatures for locally advanced, well-differentiated thyroid cancers.

Through the use of next-generation sequencing, it was determined that advanced thyroid cancers are more likely to have multiple mutations than less advanced disease, explains Duvvuri.

Most commonly these advanced cancers seem to have a combination of a 

 mutation as well as mutation of the promoter region of telomerase reverse transcriptase (hTERT). This may indicate that these two mutations together can cause more aggressive thyroid cancers to form, says Duvvuri.

View more from the 2015 International Thyroid Congress

Conference

® Conference page includes a listing of all conferences covered by 

, including the ASCO, ESMO, SITC, EHA, ASH, and SABCS annual meetings, as well as the Chemotherapy Foundation Symposium and Miami Breast Cancer Conference, among many others. Conference coverage incorporates articles and interviews in written and video format.


Head & Neck Cancers

The OncLive Head and Neck Cancer condition center page is a comprehensive resource for clinical news and expert insights on treatment for patients with head and neck cancer. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research within head and neck cancer. 

International Thyroid Congress

Umamaheswar Duvvuri, MD, PhD, Assistant Professor of Otolaryngology (ENT) at the University of Pittsburgh Medical Center, talks about potential genetic signatures for locally advanced, well differentiated thyroid cancers.

Dr. Umamaheswar Duvvuri on Impact of Multiple Genetic Mutations in Advanced Thyroid Cancer